发明名称 |
Pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppresive action of aggressive agents on the skin |
摘要 |
The object of the invention is a mixture of catechin and quercetin in a molar ratio varying between 3:1 and 6:1, respectively, for the treatment of the immunosuppression induced in the skin by aggressive agents such as airborne pollutants, dehydrating agents, ultraviolet radiation, and thermal and osmotic shocks, and a pharmaceutical, dermatological, nutritional or cosmetic composition containing said mixture as an active ingredient. |
申请公布号 |
US9138394(B2) |
申请公布日期 |
2015.09.22 |
申请号 |
US201013260245 |
申请日期 |
2010.04.30 |
申请人 |
GIULIANI S.P.A. |
发明人 |
Giuliani Giammaria;Benedusi Anna |
分类号 |
A61K31/353;A61Q17/04;A61K8/49;A61P37/00;A61P29/00;A23L1/30;A61K9/00;A61K9/06;A61K9/20;A61K9/48;A61K31/352;A61Q19/00 |
主分类号 |
A61K31/353 |
代理机构 |
DLA Piper LLP (US) |
代理人 |
DLA Piper LLP (US) |
主权项 |
1. A method of treatment of the human skin by protective action thereof from immunosuppression induced in the skin by aggressive agents including airborne pollutants, dehydrating agents, ultraviolet rays, and thermal and osmotic shocks, wherein the method comprises:
administering topically an effective amount of a mixture of catechin and quercetin in a molar ratio approximately in the range of 6:1 to 3:1, as an active ingredient in a pharmaceutical, dermatological, nutritional or cosmetic composition, to effect the protective action against immunosuppression in the skin, wherein the protective action comprises a combination of increased IL-10 expression, reduced IL-12 or TNF-α expression, inhibition of thymine dimers, and inhibition of 8 oxy D-guanosine, and wherein the protective action on the skin comprises an anti-inflammatory activity. |
地址 |
Milan IT |